Clinical Trial Update: Cilostazol After Lower Extremity Arterial Revascularization Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cilostazol after lower extremity arterial revascularization; terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Peripheral Arterial Disease, Claudication (Finding) | Phase 4 | Status: TERMINATED | Results posted: 2018-11-23